Uppsala Reports Long Reads – Patient's advocate

In November 2020, longstanding UMC director Marie Lindquist began
her well-earned retirement, leaving the reins of the organisation
to her successor Hervé Le Louët. As she prepared to open a new
chapter in her life, she sat down with Uppsala Reports to take a
fond look back at an extraordinary career: a 40-year-long path
that began with a knock on the door and turned her into one of
the world’s leading advocates for patient safety.

This episode is part of the Uppsala Reports Long Reads series –
the most topical stories from UMC’s pharmacovigilance magazine,
brought to you in audio format. Find the original article
here.

Tune in to find out:


Why monitoring the safety of medicines and vaccines matters
more than ever during the COVID-19 pandemic

How UMC’s methods and tools have advanced the science of
pharmacovigilance 

Why it’s important to see the patient behind the data



Want to know more?Uppsala Monitoring Centre has been
leading a global effort to improve the science of
pharmacovigilance for more than 40 years.

You can read a comprehensive history of the organisation in the
book Making Medicines Safer.

If you’d like free regular updates from the world of
pharmacovigilance, subscribe to the monthly Uppsala Reports
newsletter.





Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.